XML 12 R2.htm IDEA: XBRL DOCUMENT v3.6.0.2
CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)
Oct. 31, 2016
Jul. 31, 2016
Current Assets:    
Cash and cash equivalents $ 6,454 $ 16,899
Other current assets 11,353 8,077
Total Current Assets 17,807 24,976
Property and Equipment, Net 1,298
TOTAL ASSETS 17,807 26,274
Current Liabilities:    
Accounts payable and accrued expenses 9,154,886 8,950,870
Loan payable 50,000 50,000
Total Current Liabilities 9,204,886 9,000,870
Derivative Warrant Liability 1,462,359 2,048,846
Derivative Additional Investment Rights Liability 193,408
Total Liabilities 10,667,245 11,243,124
Stockholders' Deficiency (Note 7):    
9% Convertible Preferred Stock
Common stock, $.001 par value; authorized 2,450,000,000 and 2,450,000,000 shares at October 31, 2016 and July 31, 2016, respectively; 908,541,475 and 908,541,475 issued and outstanding at October 31, 2016 and July 31, 2016, respectivelyCommon stock, $.001 par value; authorized 2,450,000,000 and 1,500,000,000 shares at October 31, 2016 and July 31, 2016, respectively; 908,541,475 and 908,541,475 issued and outstanding at October 31, 2016 and July 31, 2016, respectively 908,542
Additional paid-in capital 362,780,108 362,780,108
Accumulated deficit (375,144,134) (375,704,372)
Accumulated other comprehensive income 806,046 798,872
Total Stockholders' Deficiency (10,649,438) (11,216,850)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIENCY 17,807 26,274
Series A Convertible Preferred Stock    
Stockholders' Deficiency (Note 7):    
9% Convertible Preferred Stock
Series B Convertible Preferred Stock    
Stockholders' Deficiency (Note 7):    
9% Convertible Preferred Stock
Series C Convertible Preferred Stock    
Stockholders' Deficiency (Note 7):    
9% Convertible Preferred Stock
Series D Convertible Preferred Stock    
Stockholders' Deficiency (Note 7):    
9% Convertible Preferred Stock
Series E Convertible Preferred Stock    
Stockholders' Deficiency (Note 7):    
9% Convertible Preferred Stock
Series F Convertible Preferred Stock    
Stockholders' Deficiency (Note 7):    
9% Convertible Preferred Stock
Series G Convertible Preferred Stock    
Stockholders' Deficiency (Note 7):    
9% Convertible Preferred Stock